Fig. 2
From: Idarucizumab for a traumatic head injury patient taking dabigatran

Head CT 3 h after admission showed the expansion of the temporal lobe hematoma
From: Idarucizumab for a traumatic head injury patient taking dabigatran
Head CT 3 h after admission showed the expansion of the temporal lobe hematoma